nimodipine has been researched along with Retinal Neovascularization in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nimodipine can inhibit the expression of VEGF at certain degrees." | 1.32 | [Experimental study of nimodipine and vascular endothelial growth factor in proliferative retinopathy]. ( Deng, DY; Han, LR; Kong, Y; Peng, YJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, Y | 1 |
| Han, LR | 1 |
| Peng, YJ | 1 |
| Deng, DY | 1 |
1 other study available for nimodipine and Retinal Neovascularization
| Article | Year |
|---|---|
[Experimental study of nimodipine and vascular endothelial growth factor in proliferative retinopathy].
Topics: Animals; Calcium Channel Blockers; Nimodipine; Rats; Rats, Sprague-Dawley; Retinal Diseases; Retinal | 2004 |